Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
57,790
-436
-0.7% -$149K 0.1% 169
2026
Q1
$20.5M Sell
58,226
-5,441
-9% -$1.94M 0.11% 163
2025
Q4
$20.8M Sell
63,667
-1,697
-3% -$538K 0.11% 157
2025
Q3
$18.4M Sell
65,364
-459
-0.7% -$133K 0.1% 174
2025
Q2
$18.4M Buy
65,823
+1,544
+2% +$437K 0.1% 165
2025
Q1
$20M Buy
64,279
+1,056
+2% +$312K 0.12% 157
2024
Q4
$16.5M Buy
63,223
+5,736
+10% +$1.7M 0.09% 174
2024
Q3
$18.5M Sell
57,487
-2,293
-4% -$750K 0.11% 158
2024
Q2
$18.7M Buy
59,780
+2,946
+5% +$865K 0.11% 155
2024
Q1
$16.2M Sell
56,834
-1,690
-3% -$495K 0.1% 169
2023
Q4
$16.9M Sell
58,524
-5,264
-8% -$1.43M 0.11% 152
2023
Q3
$17.1M Buy
63,788
+967
+2% +$241K 0.13% 142
2023
Q2
$13.9M Buy
62,821
+6,204
+11% +$1.44M 0.1% 153
2023
Q1
$13.7M Buy
56,617
+2,636
+5% +$647K 0.11% 154
2022
Q4
$14.2M Sell
53,981
-5,926
-10% -$1.59M 0.12% 149
2022
Q3
$13.5M Buy
59,907
+3,931
+7% +$953K 0.12% 143
2022
Q2
$13.6M Sell
55,976
-1,722
-3% -$422K 0.11% 147
2022
Q1
$14M Buy
57,698
+1,820
+3% +$418K 0.1% 156
2021
Q4
$12.6M Sell
55,878
-952
-2% -$201K 0.08% 165
2021
Q3
$12.1M Buy
56,830
+7,589
+15% +$1.75M 0.09% 157
2021
Q2
$12M Sell
49,241
-5,563
-10% -$1.37M 0.09% 153
2021
Q1
$13.6M Buy
54,804
+5,202
+10% +$1.24M 0.13% 122
2020
Q4
$11.4M Buy
49,602
+2,880
+6% +$664K 0.11% 127
2020
Q3
$11.9M Sell
46,722
-2,463
-5% -$610K 0.13% 117
2020
Q2
$11.6M Buy
49,185
+495
+1% +$113K 0.14% 115
2020
Q1
$9.87M Sell
48,690
-464
-0.9% -$101K 0.14% 110
2019
Q4
$11.8M Sell
49,154
-1,148
-2% -$253K 0.13% 117
2019
Q3
$9.27M Sell
50,302
-180
-0.4% -$34.6K 0.11% 123
2019
Q2
$9.3M Buy
50,482
+2,953
+6% +$529K 0.11% 120
2019
Q1
$9.03M Sell
47,529
-1,182
-2% -$226K 0.11% 120
2018
Q4
$9.48M Buy
48,711
+410
+0.8% +$80K 0.13% 117
2018
Q3
$10M Buy
48,301
+3,149
+7% +$621K 0.12% 125
2018
Q2
$8.34M Sell
45,152
-174,370
-79% -$30.8M 0.1% 133
2018
Q1
$37.4M Sell
219,522
-2,313
-1% -$425K 0.46% 92
2017
Q4
$38.6M Sell
221,835
-4,425
-2% -$783K 0.46% 93
2017
Q3
$42.2M Sell
226,260
-16,693
-7% -$2.96M 0.53% 77
2017
Q2
$41.8M Buy
242,953
+99
+0% +$16.1K 0.55% 73
2017
Q1
$36.2M Sell
242,854
-2,116
-0.9% -$352K 0.52% 76
2016
Q4
$35.8M Buy
244,970
+1,626
+0.7% +$245K 0.51% 82
2016
Q3
$40.6M Buy
243,344
+4,184
+2% +$708K 0.6% 64
2016
Q2
$36.4M Buy
239,160
+474
+0.2% +$73.7K 0.55% 65
2016
Q1
$35.8M Buy
238,686
+934
+0.4% +$139K 0.56% 70
2015
Q4
$38.6M Buy
237,752
+1,851
+0.8% +$291K 0.62% 59
2015
Q3
$32.6M Sell
235,901
-6,560
-3% -$1.03M 0.55% 70
2015
Q2
$37.2M Buy
242,461
+909
+0.4% +$146K 0.58% 65
2015
Q1
$38.6M Sell
241,552
-1,938
-0.8% -$305K 0.59% 59
2014
Q4
$38.8M Sell
243,490
-70,853
-23% -$11M 0.63% 58
2014
Q3
$44.2M Buy
314,343
+44
+0% +$5.75K 0.77% 43
2014
Q2
$37.2M Buy
314,299
+5,947
+2% +$688K 0.63% 58
2014
Q1
$38M Buy
308,352
+14,921
+5% +$1.81M 0.69% 48
2013
Q4
$33.5M Buy
293,431
+1,065
+0.4% +$121K 0.63% 62
2013
Q3
$32.7M Buy
292,366
+2,064
+0.7% +$224K 0.67% 57
2013
Q2
$28.6M Buy
+290,302
New +$30.1M 0.63% 61

Other funds holding AMGN

Davenport & Co's AMGN Position: Q2 2026 in Review

Davenport & Co reduced its Amgen (AMGN) stake by 0.75% in Q2 2026, selling an estimated $149K and leaving 57,790 shares worth $20.9M. The position accounts for 0.1% of the portfolio, ranked #169.

Davenport & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $44.2M in Q3 2014. 790 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Davenport & Co held 57,790 shares of Amgen worth $20.9M as of Q2 2026.
  • Davenport & Co sold 436 Amgen shares in Q2 2026, an estimated $149K.
  • Amgen made up 0.1% of Davenport & Co's portfolio in Q2 2026, its #169 holding.
  • Davenport & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Amgen position peaked at $44.2M in Q3 2014.
  • 790 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.